inflamed pharma
PrivateLast Round
Grant
Mar 23, 2020
Company Overview
inflamed pharma operates in Healthcare & Life Sciences and is based in Jena. Its latest recorded funding round was a Grant round in March 2020.
inflamed pharma is a biotechnology company that provides a patented technology platform, JenCluTec®, to increase the water solubility and membrane permeability of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inflamed pharma Comparables
Compare inflamed pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zerion Pharma | 86% | |
| Harpago | 82% | |
| AustinPx | 79% |
For institutional investors. Book with your work email.
inflamed pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
inflamed pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Xlife Sciences AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2020
Received grant funding from the European Regional Development Fund.
For institutional investors. Book with your work email.
inflamed pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about inflamed pharma's valuation, stock price, and market status.
Is inflamed pharma a public or private company?
inflamed pharma is a private company.
What is the current stock price of inflamed pharma?
inflamed pharma is a private company, so its shares have no public market price. Caplight tracks inflamed pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is inflamed pharma worth (valuation)?
Valuation information for inflamed pharma is not publicly available.
Can I buy inflamed pharma stock?
inflamed pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was inflamed pharma's last funding round?
inflamed pharma's most recent funding round was Grant on March 23, 2020.
Who are the main investors in inflamed pharma?
Key investors in inflamed pharma include Xlife Sciences AG.
Will inflamed pharma IPO soon?
No public IPO plans have been announced for inflamed pharma.
How can I track inflamed pharma secondary market activity?
Caplight tracks bids, offers, and trades in inflamed pharma's shares on secondary markets.